Results 101 to 110 of about 428 (129)
Some of the next articles are maybe not open access.

Primary Monosymptomatic Nocturnal Enuresis: Monotherapy vs Combination Therapy

Urology, 2016
To evaluate the clinical results of monotherapy with combination therapy in treatment of primary monosymptomatic nocturnal enuresis (PMNE) in children.Between December 2008 and May 2013, we reviewed the records of 176 children with PMNE. The monotherapy group received 120 micrograms of desmopressin melt whereas the combination therapy group received ...
Farzaneh, Sharifiaghdas   +2 more
openaire   +2 more sources

INTERMITTENT ORAL DESMOPRESSIN THERAPY FOR MONOSYMPTOMATIC PRIMARY NOCTURNAL ENURESIS

Journal of Urology, 2004
In a prospective study we evaluate the efficacy of intermittent desmopressin (DDAVP) every other day for patients with nocturnal enuresis relapse who need additional therapy.Between January 2000 and August 2001, 71 boys and 52 girls 6 to 22 years old (mean age 12.5) were treated with 0.2 mg DDAVP daily for monosymptomatic nocturnal enuresis.
Cem, Akbal   +3 more
openaire   +2 more sources

Urinary Calcium Excretion in Healthy Children and Children With Primary Monosymptomatic Nocturnal Enuresis

Journal of Urology, 2006
We investigated the role of urinary Ca excretion in monosymptomatic nocturnal enuresis, and defined normality and intra-individual variability in Ca excretion in healthy children.We included 46 Danish children with desmopressin resistant nocturnal enuresis and 96 healthy controls.
Kamperis, Konstantinos; id_orcid 0000-0003-0104-4884   +3 more
openaire   +3 more sources

Primary monosymptomatic nocturnal enuresis in children and adolescents.

International journal of clinical practice. Supplement, 2008
Nocturnal enuresis (NE) is one of the most frequent paediatric pathologies. The prevalence of primary nocturnal enuresis (PNE) is around 9% in children between 5 and 10 years of age and about 40% of them have one or more episodes per week. Still for too long, PNE has not been recognised as a pathological condition, particularly by the medical community;
H B, Lottmann, I, Alova
openaire   +1 more source

Development of a novel scale for primary monosymptomatic nocturnal enuresis: Nocturnal Enuresis Symptom Score (NESS)

Journal of Pediatric Urology
Monosymptomatic nocturnal enuresis (MNE) is defined as urinary incontinence occurring during sleep in absence of daytime lower urinary tract symptoms. International Children Continence Society (ICCS) classifies treatment success as complete response (100 % resolution of symptoms), partial response (50-99 % reduction in symptoms) and no response (
Cagri Akin Sekerci   +8 more
openaire   +2 more sources

The role of pelvic traction in the management of primary monosymptomatic nocturnal enuresis

BJU International, 2002
Objective To determine whether pelvic traction is beneficial in children with primary nocturnal enuresis. Patients and methods There can be disproportionate growth between the spinal column and neural tube in prepubertal children.
openaire   +2 more sources

Is There Still a Role for Desmopressin in Children with Primary Monosymptomatic Nocturnal Enuresis?

Drug Safety, 2010
It has recently became apparent that severe primary monosymptomatic nocturnal enuresis (MNE) has a worse prognosis than generally believed, and may have major consequences on the well-being of the child, thus making treatment mandatory. Desmopressin is one of the most widely prescribed medications for MNE, and in this current opinion article we discuss
Johan, Van de Walle   +2 more
openaire   +2 more sources

Functional bladder capacity and urine osmolality in children with primary monosymptomatic nocturnal enuresis

Scandinavian Journal of Urology and Nephrology, 2005
To assess functional day-time bladder capacity (DBC) and urine osmolality in children with primary monosymptomatic nocturnal enuresis (PMNE) according to age and sex.A total of 263 children with PMNE were divided into two groups: Group I, 160 children (63 girls, 97 boys) aged 5-9 years (mean age 7.14+/-1.47 years); and Group II, 103 children (25 girls,
Agata, Korzeniecka-Kozerska   +2 more
openaire   +2 more sources

The optimal duration of alarm therapy use in children with primary monosymptomatic nocturnal enuresis

Journal of Pediatric Urology, 2018
The prevalence of primary monosymptomatic nocturnal enuresis (PMNE) has a range of 1.6-5.3% in adolescents and 7.5-12.4% in children of 5-10 years. Alarm intervention has been well known for more than 30 years. This method is a reliable and safe means of treating primary monosymptomatic nocturnal enuresis, being effective in 60-80% of cases.The ...
Kirill V. Kosilov   +6 more
openaire   +3 more sources

[Etiology primary, monosymptomatic nocturnal enuresis in children. Own research].

Medycyna wieku rozwojowego, 2014
Primary monosymptomatic nocturnal enuresis is the most frequent (85%) type of enuresis in children. Establishing its causes enables the choice of effective therapy.To establish the causes of primary, monosymptomatic nocturnal enuresis in children on the basis of own investigations.The study concerned 47 children (36 boys and 21 girls) with primary ...
Bożena, Eberdt-Gołąbek   +3 more
openaire   +1 more source

Home - About - Disclaimer - Privacy